Huadong Medicine Co., Ltd (SHE:000963)

Huadong Medicine Revenue

Huadong Medicine had revenue of 10.95B CNY in the quarter ending September 30, 2026, a decrease of -0.33%. This brings the company's total for the last twelve months to 43.97B, up 2.03% year-over-year. In the year 2025, Huadong Medicine had annual revenue of 43.61B with 4.07% growth. That makes Huadong Medicine the 2,109th largest company in the world by revenue and 224th in China.

• Revenue (ttm): 43.97B
• Revenue Growth: +2.03%
• P/S Ratio: 1.06
• Revenue / Employee: 2.30M
• Employees: 19,095
• Market Cap: 46.68B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Commercial Business 30.49B 65.6%
• Manufacturing 14.56B 31.3%
• Medical Beauty Business 1.40B 3.0%

By Geography

Chart

• China 42.49B 97.4%
• Foreign 1.13B 2.6%

Fiscal year ended Dec 31, 2025 See the full Huadong Medicine breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	43.61B	1.71B	4.07%
Dec 31, 2024	41.91B	1.28B	3.16%
Dec 31, 2023	40.62B	2.91B	7.71%
Jan 1, 2023	37.71B	3.15B	9.12%
Jan 1, 2022	34.56B	880.24M	2.61%

Data Source: S&P Global Market Intelligence Last updated: Oct 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 31, 2026

Data Sources Report a data error